Search Result

Results for "

phosphatase+inhibitor

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Akt (1) Antibiotic (3) Apoptosis (4) Bacterial (4) Drug Derivative (1) Endogenous Metabolite (3) ERK (3) Histone Methyltransferase (2) PERK (1) Phosphatase (41) Reference Standards (4) SHP1 (2) SHP2 (2)
By Research Areas:	Cancer (28) Cardiovascular Disease (2) Infection (5) Inflammation/Immunology (1) Metabolic Disease (7)

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

MCE Kits

Natural
Products

Recombinant Proteins

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-D0886

β-Glycerophosphate disodium salt pentahydrate 25+ Cited Publications	Phosphatase Endogenous Metabolite ERK	Metabolic Disease Cancer
β-Glycerophosphate disodium salt pentahydrate is a bioactive endogenous metabolite and a *phosphatase* inhibitor. β-Glycerophosphate disodium salt pentahydrate plays an important role in inducing and maintaining osteoblast differentiation, mineral metabolism and signal transduction, and can be used as a drug carrier to form heat-sensitive hydrogels. β-Glycerophosphate disodium salt hydrate accelerates the calcification of vascular smooth muscle cells .

HY-126304

β-Glycerophosphate disodium salt hydrate 25+ Cited Publications	Phosphatase Endogenous Metabolite ERK	Metabolic Disease
β-Glycerophosphate disodium salt pentahydrate is a bioactive endogenous metabolite and a *phosphatase* inhibitor. β-Glycerophosphate disodium salt pentahydrate plays an important role in inducing and maintaining osteoblast differentiation, mineral metabolism and signal transduction, and can be used as a drug carrier to form heat-sensitive hydrogels. β-Glycerophosphate disodium salt hydrate accelerates the calcification of vascular smooth muscle cells .

HY-100463

TPI-1 15+ Cited Publications	SHP1 Phosphatase	Inflammation/Immunology Cancer
TPI-1, also known as Tyrosine Phosphatase Inhibitor 1, is a SHP-1 inhibitor; inhibits recombinant SHP-1 with an IC₅₀ of 40 nM.

HY-15832

GSK 2830371 10+ Cited Publications	Phosphatase	Cancer
GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC₅₀ of 6 nM.

HY-18686

AS1949490 1 Publications Verification	Phosphatase Akt	Metabolic Disease
AS1949490 is a potent, orally active, selective SHIP2 phosphatase inhibitor with IC₅₀ values of 0.34, 0.62, 13, >50, >50, and >50 µM for Mouse SHIP2, Human SHIP2, Human SHIP1, Human PTEN, Human synaptojanin, and Human myotubularin, respectively. AS1949490 increases the phosphorylation of Akt, glucose consumption and glucose uptake. AS1949490 activates intracellular insulin signalling pathways. AS1949490 can be used for research of diabetes .

HY-108543

NSC 95397 5+ Cited Publications	Phosphatase Apoptosis	Cancer
NSC 95397 is a potent, selective Cdc25 dual specificity phosphatase inhibitor (K_i=32 nM (Cdc25A), 96 nM (Cdc25B), 40 nM (Cdc25C); IC₅₀=22.3 nM (human Cdc25A), 56.9 nM (human Cdc25C), 125 nM (Cdc25B)) . NSC 95397 inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) and suppresses proliferation and induces apoptosis in colon cancer cells through MKP-1 and ERK1/2 pathway .

HY-19695

(-)-p-Bromotetramisole oxalate 1 Publications Verification L-p-Bromotetramisole oxalate; 6-Bromolevamisole oxalate	Phosphatase	Cancer
(-)-p-Bromotetramisole oxalate (L-p-Bromotetramisole oxalate) is an alkaline phosphatase inhibitor. (-)-p-Bromotetramisole (oxalate) is applicable to research related to erythroleukemia .

HY-124756

SBI-425 3 Publications Verification	Phosphatase	Cardiovascular Disease
SBI-425 is an orally active and potent TNAP (tissue-nonspecific alkaline phosphatase) inhibitor (IC₅₀=16 nM). SBI-425 inhibits TNAP in the vasculature, improving cardiovascular parameters and survival .

HY-118567

Bis(maltolato)oxovanadium(IV) BMOV	SHP2 Phosphatase	Metabolic Disease
Bis(maltolato)oxovanadium(IV) (BMOV) is a potent, reversible, competitive and orally active pan-PTP (protein tyrosine phosphatases) inhibitor. Bis(maltolato)oxovanadium(IV) inhibits HCPTPA, PTP1B, HPTPβ and SHP2 with IC₅₀s of 126 nM, 109 nM, 26 nM and 201 nM, respectively. Bis(maltolato)oxovanadium(IV) is a potent insulin sensitizer .

HY-13588

Cefsulodin sodium SCE-129 sodium	Bacterial Antibiotic	Infection
Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC₅₀ value of 16 μM .

HY-100034

NSC 663284 5+ Cited Publications DA-3003-1	Phosphatase Histone Methyltransferase	Cancer
NSC 663284 (DA-3003-1) is a potent, cell-permeable, and irreversible Cdc25 dual specificity phosphatase inhibitor, has an IC₅₀ for Cdc25B2 of 0.21 μM. NSC 663284 exhibits mixed competitive kinetics against Cdc25A, Cdc25B(2), and Cdc25C with Ki values of 29, 95, and 89 nM, respectively . NSC 663284 inhibits NSD2 (IC₅₀ of 170 nM) through a direct interaction with the catalytic SET domain (K_d of 370 nM) .

HY-P2040

Nodularin	Phosphatase	Cancer
Nodularin is a potent hepatotoxin, tumor promoter, and protein phosphatase inhibitor .

HY-128153

Thienopyridone 1 Publications Verification	Phosphatase Apoptosis	Cancer
Thienopyridone is a potent and selective **phosphatase of regenerating liver (PRL) phosphatase** inhibitor with IC₅₀s of 173 nM, 277 nM and 128 nM for PRL-1, PRL-2, and PRL-3, respectively. Thienopyridone shows minimal effects on other phosphatases. Thienopyridone induces p130Cas cleavage and apoptosis and has anticancer effects .

HY-133511

MLS000544460	Phosphatase	Cancer
MLS000544460 is a highly selective and reversible Eya2 phosphatase inhibitor with a K_d of 2.0 μM and an IC₅₀ of 4 μM. MLS000544460 inhibit Eya2 phosphatase mediated cell migration and has anti-cancer activity .

HY-125259

SHP504	SHP2 Phosphatase	Cancer
SHP504 is a SHP2 phosphatase inhibitor, with an IC₅₀ of 21 μM for SHP2 ^1–525 .

HY-W024644

Hydroxyethylthio Vitamine K3	Phosphatase	Cancer
Hydroxyethylthio Vitamin K3 is a Cdc25 phosphatase inhibitor, with IC₅₀ values of 4.56 μM and 23.63 μM for Cdc25A and Cdc25B, respectively. Hydroxyethylthio Vitamin K3 can be used in tumor research .

HY-15832A

(R)-GSK 2830371	Phosphatase	Others
(R)-GSK 2830371 is the R-enantiomer of GSK 2830371 (HY-15832). GSK 2830371 is a highly selective Wip1 phosphatase inhibitor with IC50 of 6 nM .

HY-N12177

Cryptosporioptide A	Phosphatase SHP1	Metabolic Disease
Cryptosporioptide A (Compound 3) is a pigment protein tyrosine phosphatase inhibitor derived from the insect-parasitic fungus Cordyceps gracilioides. Cryptosporioptide A inhibits PTP1B, SHP2, CDC25B, LAR and SHP1 enzymes with IC₅₀ of 7.3, 5.7, 7.6, >50, 4.9 μg/mL, respectively .

HY-118529

JUN-1111	Phosphatase	Cancer
JUN-1111 is an irreversible and selective Cdc25 phosphatase inhibitor with IC₅₀ values of 0.38, 1.8, 0.66, 28, 37 µM for Cdc25A, Cdc25B, Cdc25C, VHR, PTP1B, respectively. JUN-1111 induces cell cycle arrest at G1 and G2/M phases. JUN-1111 decreases the expression of phosphoCdk1 .

HY-126304R

β-Glycerophosphate disodium salt hydrate (Standard)	Reference Standards Phosphatase Endogenous Metabolite ERK	Metabolic Disease
β-Glycerophosphate disodium salt hydrate (Standard) is the analytical standard of β-Glycerophosphate disodium salt hydrate (HY-126304). This product is intended for research and analytical applications. β-Glycerophosphate disodium salt pentahydrate is a bioactive endogenous metabolite and a phosphatase inhibitor. β-Glycerophosphate disodium salt pentahydrate plays an important role in inducing and maintaining osteoblast differentiation, mineral metabolism and signal transduction, and can be used as a drug carrier to form heat-sensitive hydrogels. β-Glycerophosphate disodium salt hydrate accelerates the calcification of vascular smooth muscle cells.

HY-113821

1-Naphthyl phosphate potassium salt	Phosphatase	Others
1-Naphthyl phosphate potassium salt is a non-specific *phosphatase* inhibitor. 1-Naphthyl phosphate potassium salt decreases the splice-correcting effect .

HY-178285

VHR-IN-2	Phosphatase	Cancer
VHR-IN-2 (Compound SA9) is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 3.1 μM. VHR-IN-2 can be used for the research of cervical cancer .

HY-178294

VHR-IN-4	Phosphatase	Cancer
VHR-IN-4 (Compound SA7) is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 1.8 μM. VHR-IN-4 can be used for the research of cervical cancer .

HY-124044

ML 086	Phosphatase	Cardiovascular Disease
ML 086 is a highly selective PHOSPHO1 phosphatase inhibitor (IC₅₀=0.14 μM). ML 086 is promising for research of hereditary vascular calcification disorders (e.g., generalized arterial calcification of infancy) and spinal ligament ossification .

HY-178292

VHR-IN-3	Phosphatase	Cancer
VHR-IN-3 (Compound 1) is a selective vaccinia H1-related (VHR) phosphatase inhibitor with a K_i of 0.81 μM. VHR-IN-3 mimics the phosphate group through the sulfonic acid group and competitively binds to the catalytic active center of VHR. VHR-IN-3 can be used for the research of cervical cancer .

HY-135477

RWJ-60475	Phosphatase Bacterial	Infection
RWJ-60475 is a cell-permeable tyrosine phosphatase inhibitor with an IC₅₀ of 3.3 μM. RWJ-60475, by inhibiting the activity of CD45/CD148 phosphatase, interferes with the phagocytic function of macrophages, thereby blocking the invasion of Legionella pneumophila into host cells and the transport of effector proteins. RWJ-60475 significantly reduces the uptake of bacterial particles by macrophages. RWJ-60475 can be used in the research of anti-infection targeting host factors .

HY-178297

VHR-IN-7	Phosphatase	Cancer
VHR-IN-7 is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 71 nM. VHR-IN-7 shows very weaker inhibitory activity against MKP-1 (IC₅₀ = 0.47 μM), CD45 (IC₅₀ = 0.3 μM), Cdc25A (IC₅₀ = 3.4 μM), PTP1B (IC₅₀ = 0.59 μM), and HePTP (IC₅₀ = 1.2 μM). VHR-IN-7 inhibits the proliferation of HeLa cells. VHR-IN-7 can be used for the research of cervical cancer .

HY-178296

VHR-IN-6	Phosphatase	Cancer
VHR-IN-6 is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 74 nM. VHR-IN-6 shows very weaker inhibitory activity against MKP-1 (IC₅₀ = 0.52 μM), CD45 (IC₅₀ = 0.50 μM), Cdc25A (IC₅₀ = 2.8 μM), PTP1B (IC₅₀ = 0.42 μM), and HePTP (IC₅₀ = 0.87 μM). VHR-IN-6 inhibits the proliferation of HeLa cells. VHR-IN-6 can be used for the research of cervical cancer .

HY-178301

VHR-IN-9	Phosphatase	Cancer
VHR-IN-9 is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 270 nM. VHR-IN-9 shows very weaker inhibitory activity against MKP-1 (IC₅₀ = 2.8 μM), CD45 (IC₅₀ = 1.8 μM), Cdc25A (IC₅₀ = > 10 μM), PTP1B (IC₅₀ = 2.2 μM), and HePTP (IC₅₀ = 2.4 μM). VHR-IN-9 inhibits the proliferation of HeLa cells. VHR-IN-9 can be used for the research of cervical cancer .

HY-P1984

Alphostatin	Phosphatase	Others
Alphostatin is a bovine liver alkaline phosphatase inhibitor .

HY-N3267

Methyl pseudolarate B	Phosphatase	Metabolic Disease
Methyl pseudolarate B, a natural diterpenoid, is a *protein tyrosine phosphatase* 1B (PTP1B)** (Phosphatase) inhibitor with an IC₅₀ value of 10.9 μM .

HY-152168

NSC 295642	PERK Phosphatase	Cancer
NSC 295642 is a *phosphatase* inhibitor. NSC 295642 can significantly increase phospho-Erk cytonuclear differences in intact cells. NSC 295642 can be used for the research of cancer .

HY-N12776

Illudalic acid	Phosphatase	Cancer
Illudalic acid is a potent and selective Leukocyte antigen-related (LAR) phosphatase inhibitor with an IC₅₀ value of 1.30 µM. Illudalic acid inhibits LAR phosphatase through covalent ligation to the catalytic cysteine residue .

HY-128024

VHR-IN-1	Phosphatase	Cancer
VHR-IN-1 (Compound SA1) is a potent and selective VHR phosphatase inhibitor with an IC₅₀ of 18 nM. VHR-IN-1 can inhibit the proliferation of cervix cancer cells and has anti-tumor activity .

HY-178303

VHR-IN-8	Phosphatase	Cancer
VHR-IN-8 (Compound SA8) is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 2.4 μM. VHR-IN-8 can be used for the research of cervical cancer .

HY-13588B

Cefsulodin sodium hydrate SCE-129 sodium hydrate	Antibiotic Bacterial	Infection
Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC₅₀ value of 16 μM .

HY-13588R

Cefsulodin sodium (Standard) SCE-129 sodium (Standard)	Reference Standards Bacterial Antibiotic	Infection
Cefsulodin (sodium) (Standard) is the analytical standard of Cefsulodin (sodium). This product is intended for research and analytical applications. Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC₅₀ value of 16 μM .

HY-178295

VHR-IN-5	Phosphatase	Cancer
VHR-IN-5 is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC₅₀ of 78 nM. VHR-IN-5 shows very weaker inhibitory activity against MKP-1 (IC₅₀ = 0.78 μM), CD45 (IC₅₀ = 0.61 μM), Cdc25A (IC₅₀ = 3.4 μM), PTP1B (IC₅₀ = 1.8 μM), and HePTP (IC₅₀ = 1.5 μM). VHR-IN-5 inhibits the proliferation of HeLa cells. VHR-IN-5 can be used for the research of cervical cancer .

HY-180456

Phosphatase-IN-2	Phosphatase	Infection
Phosphatase-IN-2 (Compound 26) is a CpxA phosphatase inhibitor. Phosphatase-IN-2 can be used in the research of Escherichia coli infection .

HY-183947

4-Bromolevamisole	Phosphatase Drug Derivative	Cancer
4-Bromolevamisole, an analogues of Levamisole (HY-A0106), is a *phosphatase* inhibitor. 4-Bromolevamisole potentiates the antineoplastic activity of 5-Fluorouracil (HY-90006), its analogues, or prodrugs thereof.4-Bromolevamisole can be used for cancer research .

HY-206735

CDC14A/B-IN-2	Phosphatase	Cancer
CDC14A/B-IN-2, phosphotyrosine mimetic, is a competitive human CDC14A/B *phosphatase* inhibitor with IC₅₀ values of 10.4 and 11.2 μM, and K_i values of 5.8 and 7.3 μM. CDC14A/B-IN-2 shows at least 20-fold selectivity over other protein tyrosine phosphatases. CDC14A/B-IN-2 can be used for the research of cancer .

HY-100034R

NSC 663284 (Standard) DA-3003-1 (Standard)	Phosphatase Reference Standards Histone Methyltransferase	Cancer
NSC 663284 (Standard) is the analytical standard of NSC 663284 (HY-100034). This product is intended for research and analytical applications. NSC 663284 (DA-3003-1) is a potent, cell-permeable, and irreversible Cdc25 dual specificity phosphatase inhibitor, has an IC50 for Cdc25B2 of 0.21 μM. NSC 663284 exhibits mixed competitive kinetics against Cdc25A, Cdc25B(2), and Cdc25C with Ki values of 29, 95, and 89 nM, respectively . NSC 663284 inhibits NSD2 (IC50 of 170 nM) through a direct interaction with the catalytic SET domain (Kd of 370 nM) .

HY-108543R

NSC 95397 (Standard)	Reference Standards Phosphatase Apoptosis	Cancer
NSC 95397 (Standard) is the analytical standard of NSC 95397 (HY-108543). This product is intended for research and analytical applications. NSC 95397 is a potent, selective Cdc25 dual specificity phosphatase inhibitor (K_i=32 nM (Cdc25A), 96 nM (Cdc25B), 40 nM (Cdc25C); IC₅₀=22.3 nM (human Cdc25A), 56.9 nM (human Cdc25C), 125 nM (Cdc25B)) . NSC 95397 inhibits mitogen-activated protein K_inase phosphatase-1 (MKP-1) and suppresses proliferation and induces apoptosis in colon cancer cells through MKP-1 and ERK1/2 pathway .

HY-183801

Cu2LCl2(H2O)	Phosphatase Apoptosis	Cancer
Cu₂LCl2(H2O) acts as a proteasome inhibitor and protein tyrosine phosphatase inhibitor, with antiproliferative and apoptosis-inducing effects. Cu2LCl2(H2O) exhibits low cytotoxicity against normal cells and remarkable in vivo antitumor efficacy. Cu2LCl2(H2O) inhibits proteasome activity in colon cancer cells, and suppresses PTP1B and TCPTP activities in breast cancer cells. Cu2LCl2(H2O) can be used in the research of colon cancer, breast cancer and liver cancer .

Cat. No.	Product Name

HY-L081

Phosphatase Inhibitor Library	175 compounds
Protein phosphorylation is a key post-translational modification underlying the regulation of many cellular processes. Phosphatases and kinases contribute to the regulation of protein phosphorylation homeostasis in the cell. This reversible regulation of protein phosphorylation is critical for the proper control of a wide range of cellular activities, including cell cycle, proliferation and differentiation, metabolism, cell-cell interactions, etc. Protein phosphatases have evolved in separate families that are structurally and mechanistically distinct. Based on substrate specificity and functional diversity, protein phosphatases are classified into two superfamilies: Protein serine/threonine phosphatases and Protein tyrosine phosphatases. Ser/Thr phosphatases are metalloenzymes belonging to two major gene families termed PPP (phosphoprotein phosphatase) and PPM (metal-dependent protein phosphatases), whereas protein tyrosine phosphatases (PTPs) belong to distinct classes of enzymes that utilize a phospho-cysteine enzyme intermediate as a part of their catalytic action. MCE supplies a unique collection of 175 phosphatase inhibitors that mainly targeting protein tyrosine phosphatases (PTPs) and serine/threonine-specific protein phosphatases. MCE Phosphatase Inhibitor Library is a useful tool for phosphatase drug discovery and related research.

Phosphatase Inhibitor Library

175 compounds

Protein phosphorylation is a key post-translational modification underlying the regulation of many cellular processes. Phosphatases and kinases contribute to the regulation of protein phosphorylation homeostasis in the cell. This reversible regulation of protein phosphorylation is critical for the proper control of a wide range of cellular activities, including cell cycle, proliferation and differentiation, metabolism, cell-cell interactions, etc.

Protein phosphatases have evolved in separate families that are structurally and mechanistically distinct. Based on substrate specificity and functional diversity, protein phosphatases are classified into two superfamilies: Protein serine/threonine phosphatases and Protein tyrosine phosphatases. Ser/Thr phosphatases are metalloenzymes belonging to two major gene families termed PPP (phosphoprotein phosphatase) and PPM (metal-dependent protein phosphatases), whereas protein tyrosine phosphatases (PTPs) belong to distinct classes of enzymes that utilize a phospho-cysteine enzyme intermediate as a part of their catalytic action.

MCE supplies a unique collection of 175 phosphatase inhibitors that mainly targeting protein tyrosine phosphatases (PTPs) and serine/threonine-specific protein phosphatases. MCE Phosphatase Inhibitor Library is a useful tool for phosphatase drug discovery and related research.

Cat. No.	Product Name	Type

HY-19695

(-)-p-Bromotetramisole oxalate 1 Publications Verification L-p-Bromotetramisole oxalate; 6-Bromolevamisole oxalate	Biochemical Assay Reagents
(-)-p-Bromotetramisole oxalate (L-p-Bromotetramisole oxalate) is an alkaline phosphatase inhibitor. (-)-p-Bromotetramisole (oxalate) is applicable to research related to erythroleukemia .

Cat. No.	Product Name	Target	Research Area

HY-P2040

Nodularin	Phosphatase	Cancer
Nodularin is a potent hepatotoxin, tumor promoter, and protein phosphatase inhibitor .

HY-P1984

Alphostatin	Phosphatase	Others
Alphostatin is a bovine liver alkaline phosphatase inhibitor .

Cat. No.	Product Name

HY-K0022

Phosphatase Inhibitor Cocktail Ⅱ (100× in ddH₂O) 455+ Cited Publications
Phosphatase Inhibitor Cocktail Ⅱ (100× in ddH₂O) is a blend of 5 phosphatase inhibitors that can broadly inhibit acid phosphatases, alkaline phosphatases, and protein tyrosine phosphatases (PTPs).The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0023

Phosphatase Inhibitor Cocktail Ⅲ (100× in DMSO) 240+ Cited Publications
Phosphatase Inhibitor Cocktail Ⅲ (100× in DMSO) is a mixture of multiple phosphatase inhibitors that effectively inhibit serine/threonine phosphatases and alkaline phosphatases, and is used to preserve the phosphorylation status of proteins.The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0021

Phosphatase Inhibitor Cocktail I (100× in DMSO) 670+ Cited Publications
Phosphatase Inhibitor Cocktail I (100× in DMSO) is a blend of 2 phosphatase inhibitors that can effectively inhibit alkaline phosphatases and serine/threonine phosphatases. It is used to maintain the phosphorylation status of proteins.The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0011

*Protease Inhibitor* Cocktail, mini-Tablet (EDTA-Free)** 250+ Cited Publications
MCE Protease Inhibitor Cocktail, mini-Tablet (EDTA-Free) is a blend of 5 pan-protease inhibitors for protection of protein integrity. The 25 pcs is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0016

Kinase Assay Buffer 3 Publications Verification
MCE Kinase Assay Buffer can be used for assaying kinase protein. The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0013

*Protease and Phosphatase Inhibitor* Cocktail (EDTA-Free, 10× in ddH₂O)** 140+ Cited Publications
MCE Protease and Phosphatase Inhibitor Cocktail (EDTA-Free, 10× in ddH₂O) protects protein from degradation by endogenous proteases released during protein extraction and purification.The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0010

*Protease Inhibitor* Cocktail (EDTA-Free, 100× in DMSO)** Maximum Cited Publications 1922 Publications Verification
MCE Protease Inhibitor Cocktail (EDTA-Free, 100× in DMSO) is a blend of 6 pan-protease inhibitors for protection of protein integrity.The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

HY-K0017

*Kinase Inhibitor* Cocktail** 2 Publications Verification
MCE Kinase Inhibitor Cocktail controls the biological activity of kinases. This inhibitor is primarily used for Biochemicals applications.The 1 mL volume is defined as the base specification. All larger sizes correspond to incremental volumes of this base.

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P70987

	PPP1R1A Protein, Human (His) Protein Phosphatase 1 Regulatory Subunit 1A; Protein Phosphatase Inhibitor 1; I-1; IPP-1; PPP1R1A; IPP1	Human	E. coli
	PPP1R1A Protein, Human (His) is the recombinant human-derived PPP1R1A protein, expressed by E. coli, with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks